Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. [electronic resource]
Producer: 20120111Description: 446-51 p. digitalISSN:- 1529-8019
- Adult
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Body Composition -- drug effects
- Body Weight -- drug effects
- Etanercept
- Follow-Up Studies
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Middle Aged
- Prospective Studies
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.